pentobarbital will lessen the level or influence of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with potent CYP3A4 inducers because of potential for reduced therapeutic impactpentobarbital will lessen the extent or outcome of tolterodine b